Ozempic, Wegovy and other GLP-1s shown to reduce alcohol-related hospitalizations
Ozempic, Wigovy and other GLP-1 drugs have been shown to counteract the effects of alcohol, a new study suggests. Glucagon-like peptide-1 receptor (GLP-1) agonists (including either semaglutide or liraglutide), which are prescribed to treat type 2 diabetes and obesity, have been reported to reduce alcohol intake when taken. Previous research has shown that. A new […]
